|
2025-04-04 |
2025-04-02 |
V
Vente
|
Ferguson Toby
Chief Medical Officer
Dirigeant
|
10 086
-6.0%
3,43
34 595 USD
|
10 086
-6.0%
|
3,43
|
34 595 USD
|
|
|
2025-04-04 |
2025-04-02 |
V
Vente
|
Sandrock Alfred
President and CEO
Administrateur exécutif
|
10 885
-2.5%
3,43
37 336 USD
|
10 885
-2.5%
|
3,43
|
37 336 USD
|
|
|
2025-02-24 |
2025-02-20 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
3 305
-4.1%
4,26
14 079 USD
|
3 305
-4.1%
|
4,26
|
14 079 USD
|
|
|
2025-02-24 |
2025-02-20 |
V
Vente
|
Sandrock Alfred
President and CEO
Administrateur exécutif
|
11 702
-3.8%
4,24
49 616 USD
|
11 702
-3.8%
|
4,24
|
49 616 USD
|
|
|
2025-02-24 |
2025-02-20 |
V
Vente
|
Swartz Robin
COO & CBO
Dirigeant
|
3 894
-3.8%
4,25
16 550 USD
|
3 894
-3.8%
|
4,25
|
16 550 USD
|
|
|
2025-02-12 |
2025-02-11 |
V
Vente
|
Swartz Robin
COO & CBO
Dirigeant
|
6 950
-6.4%
4,45
30 928 USD
|
6 950
-6.4%
|
4,45
|
30 928 USD
|
|
|
2025-02-12 |
2025-02-11 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
5 413
-6.3%
4,45
24 088 USD
|
5 413
-6.3%
|
4,45
|
24 088 USD
|
|
|
2025-02-12 |
2025-02-11 |
VP
Vente planifiée
|
Sandrock Alfred
President & CEO
Dirigeant
|
16 644
-5.1%
4,45
74 066 USD
|
16 644
-5.1%
|
4,45
|
74 066 USD
|
|
|
2025-02-12 |
2025-02-11 |
V
Vente
|
Fahey Sandell Jacquelyn
Chief Legal Officer
Dirigeant
|
4 358
-5.1%
4,45
19 393 USD
|
4 358
-5.1%
|
4,45
|
19 393 USD
|
|
|
2025-01-15 |
2025-01-14 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
1 191
-1.4%
5,13
6 110 USD
|
1 191
-1.4%
|
5,13
|
6 110 USD
|
|
|
2025-01-15 |
2025-01-14 |
V
Vente
|
Swartz Robin
COO & CBO
Dirigeant
|
3 087
-2.7%
5,09
15 713 USD
|
3 087
-2.7%
|
5,09
|
15 713 USD
|
|
|
2024-12-26 |
2024-12-23 |
VP
Vente planifiée
|
Swartz Robin
COO&CBO
Dirigeant
|
6 500
-5.5%
5,65
36 725 USD
|
6 500
-5.5%
|
5,65
|
36 725 USD
|
|
|
2024-10-03 |
2024-10-02 |
V
Vente
|
Fahey Sandell Jacquelyn
Chief Legal Officer
Dirigeant
|
5 999
-6.5%
5,82
34 914 USD
|
5 999
-6.5%
|
5,82
|
34 914 USD
|
|
|
2024-04-03 |
2024-04-02 |
V
Vente
|
Sandrock Alfred
President and CEO
Administrateur exécutif
|
12 115
-3.6%
9,86
119 454 USD
|
12 115
-3.6%
|
9,86
|
119 454 USD
|
|
|
2024-04-03 |
2024-04-02 |
V
Vente
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
1 357
-1.1%
9,88
13 407 USD
|
1 357
-1.1%
|
9,88
|
13 407 USD
|
|
|
2024-02-22 |
2024-02-21 |
V
Vente
|
Sandrock Alfred
President and CEO
Administrateur exécutif
|
13 033
-3.7%
7,46
97 226 USD
|
13 033
-3.7%
|
7,46
|
97 226 USD
|
|
|
2024-02-22 |
2024-02-21 |
V
Vente
|
PFREUNDSCHUH PETER P.
Chief Financial Officer
Dirigeant
|
3 764
-2.1%
7,46
28 079 USD
|
3 764
-2.1%
|
7,46
|
28 079 USD
|
|
|
2024-02-22 |
2024-02-21 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
3 365
-3.7%
7,47
25 137 USD
|
3 365
-3.7%
|
7,47
|
25 137 USD
|
|
|
2024-02-22 |
2024-02-21 |
V
Vente
|
Swartz Robin
Chief Operating Officer
Dirigeant
|
3 966
-3.2%
7,45
29 547 USD
|
3 966
-3.2%
|
7,45
|
29 547 USD
|
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
Carter Todd Alfred
Chief Scientific Officer
Dirigeant
|
602
-0.7%
7,68
4 623 USD
|
602
-0.7%
|
7,68
|
4 623 USD
|
|
